Explained: Aduhelm The New Drug To Treat Alzheimer's Disease
The United States Food and Drug Administration has approved Aduhelm for the treatment of Alzheimer's disease, a progressive neurodegenerative disease that destroys the brain's neurons and cells and impairs cognitive abilities and memory.
The United States Food and Drug Administration has approved Aduhelm for the treatment of Alzheimer's disease, a progressive neurodegenerative disease that destroys the brain's neurons and cells and impairs cognitive abilities and memory.
